Pertussis Vaccine Market in Southeast Asia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 90 pages | ID: P6CCD5816DA8EN
Market Monitor Global

Abstracts

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
This report contains market size and forecasts of Pertussis Vaccine in Southeast Asia, including the following market information:
Southeast Asia Pertussis Vaccine Market Revenue, 2015-2020, 2021-2026, ($ millions)
Southeast Asia Pertussis Vaccine Market Consumption, 2015-2020, 2021-2026, (K Doses)
Southeast Asia Pertussis Vaccine Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in Southeast Asia Pertussis Vaccine Market 2019 (%)
The global Pertussis Vaccine market was valued at 7342.7 million in 2019 and is projected to reach US$ 7535.7 million by 2026, at a CAGR of 0.7% during the forecast period. While the Pertussis Vaccine market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pertussis Vaccine manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Pertussis Vaccine production and consumption in Southeast Asia

Total Market by Segment:

Southeast Asia Pertussis Vaccine Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
Southeast Asia Pertussis Vaccine Market Segment Percentages, By Type, 2019 (%)

• Whole-cell vaccines
• Acellular vaccines

Southeast Asia Pertussis Vaccine Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Doses)
Southeast Asia Pertussis Vaccine Market Segment Percentages, By Application, 2019 (%)

• Children
• Adults

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Pertussis Vaccine Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Pertussis Vaccine Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Total Southeast Asia Pertussis Vaccine Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total Southeast Asia Pertussis Vaccine Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:

• Sanofi Pasteur
• GSK
• Mitsubishi Tanabe Pharma
• Astellas Pharma
• Minhai Biotechnology
• Wuhan Institute of Biological Products

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pertussis Vaccine Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Southeast Asia Pertussis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTHEAST ASIA PERTUSSIS VACCINE OVERALL MARKET SIZE

2.1 Southeast Asia Pertussis Vaccine Market Size: 2020 VS 2026
2.2 Southeast Asia Pertussis Vaccine Revenue, Prospects & Forecasts: 2015-2026
2.3 Southeast Asia Pertussis Vaccine Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Pertussis Vaccine Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Pertussis Vaccine Companies Ranked by Revenue
3.3 Southeast Asia Pertussis Vaccine Revenue by Companies (including Foreign and Local Companies)
3.4 Southeast Asia Pertussis Vaccine Sales by Companies (including Foreign and Local Companies)
3.5 Southeast Asia Pertussis Vaccine Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Pertussis Vaccine Companies in Southeast Asia, by Revenue in 2019
3.7 Southeast Asia Manufacturers Pertussis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pertussis Vaccine Players in Southeast Asia
  3.8.1 List of Southeast Asia Tier 1 Pertussis Vaccine Companies
  3.8.2 List of Southeast Asia Tier 2 and Tier 3 Pertussis Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Southeast Asia Pertussis Vaccine Market Size Markets, 2020 & 2026
  4.1.2 Whole-cell vaccines
  4.1.3 Acellular vaccines
4.2 By Type - Southeast Asia Pertussis Vaccine Revenue & Forecasts
  4.2.1 By Type - Southeast Asia Pertussis Vaccine Revenue, 2015-2020
  4.2.2 By Type - Southeast Asia Pertussis Vaccine Revenue, 2021-2026
  4.2.3 By Type - Southeast Asia Pertussis Vaccine Revenue Market Share, 2015-2026
4.3 By Type - Southeast Asia Pertussis Vaccine Sales & Forecasts
  4.3.1 By Type - Southeast Asia Pertussis Vaccine Sales, 2015-2020
  4.3.2 By Type - Southeast Asia Pertussis Vaccine Sales, 2021-2026
  4.3.3 By Type - Southeast Asia Pertussis Vaccine Sales Market Share, 2015-2026
4.4 By Type - Southeast Asia Pertussis Vaccine Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Southeast Asia Pertussis Vaccine Market Size, 2020 & 2026
  5.1.2 Children
  5.1.3 Adults
5.2 By Application - Southeast Asia Pertussis Vaccine Revenue & Forecasts
  5.2.1 By Application - Southeast Asia Pertussis Vaccine Revenue, 2015-2020
  5.2.2 By Application - Southeast Asia Pertussis Vaccine Revenue, 2021-2026
  5.2.3 By Application - Southeast Asia Pertussis Vaccine Revenue Market Share, 2015-2026
5.3 By Application - Southeast Asia Pertussis Vaccine Sales & Forecasts
  5.3.1 By Application - Southeast Asia Pertussis Vaccine Sales, 2015-2020
  5.3.2 By Application - Southeast Asia Pertussis Vaccine Sales, 2021-2026
  5.3.3 By Application - Southeast Asia Pertussis Vaccine Sales Market Share, 2015-2026
5.4 By Application - Southeast Asia Pertussis Vaccine Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Sanofi Pasteur
  6.1.1 Sanofi Pasteur Corporate Summary
  6.1.2 Sanofi Pasteur Business Overview
  6.1.3 Sanofi Pasteur Pertussis Vaccine Major Product Offerings
  6.1.4 Sanofi Pasteur Sales and Revenue in Southeast Asia (2015-2020)
  6.1.5 Sanofi Pasteur Key News
6.2 GSK
  6.2.1 GSK Corporate Summary
  6.2.2 GSK Business Overview
  6.2.3 GSK Pertussis Vaccine Major Product Offerings
  6.2.4 GSK Sales and Revenue in Southeast Asia (2015-2020)
  6.2.5 GSK Key News
6.3 Mitsubishi Tanabe Pharma
  6.3.1 Mitsubishi Tanabe Pharma Corporate Summary
  6.3.2 Mitsubishi Tanabe Pharma Business Overview
  6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Major Product Offerings
  6.3.4 Mitsubishi Tanabe Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.3.5 Mitsubishi Tanabe Pharma Key News
6.4 Astellas Pharma
  6.4.1 Astellas Pharma Corporate Summary
  6.4.2 Astellas Pharma Business Overview
  6.4.3 Astellas Pharma Pertussis Vaccine Major Product Offerings
  6.4.4 Astellas Pharma Sales and Revenue in Southeast Asia (2015-2020)
  6.4.5 Astellas Pharma Key News
6.5 Minhai Biotechnology
  6.5.1 Minhai Biotechnology Corporate Summary
  6.5.2 Minhai Biotechnology Business Overview
  6.5.3 Minhai Biotechnology Pertussis Vaccine Major Product Offerings
  6.5.4 Minhai Biotechnology Sales and Revenue in Southeast Asia (2015-2020)
  6.5.5 Minhai Biotechnology Key News
6.6 Wuhan Institute of Biological Products
  6.6.1 Wuhan Institute of Biological Products Corporate Summary
  6.6.2 Wuhan Institute of Biological Products Business Overview
  6.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Major Product Offerings
  6.6.4 Wuhan Institute of Biological Products Sales and Revenue in Southeast Asia (2015-2020)
  6.6.5 Wuhan Institute of Biological Products Key News
6.7 Changchun Changsheng Life Sciences
  6.6.1 Changchun Changsheng Life Sciences Corporate Summary
  6.6.2 Changchun Changsheng Life Sciences Business Overview
  6.6.3 Changchun Changsheng Life Sciences Pertussis Vaccine Major Product Offerings
  6.4.4 Changchun Changsheng Life Sciences Sales and Revenue in Southeast Asia (2015-2020)
  6.7.5 Changchun Changsheng Life Sciences Key News

7 PERTUSSIS VACCINE PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Pertussis Vaccine Production Capacity and Value in Southeast Asia, Situation Analysis and Prediction, 2015-2026
  7.1.1 Southeast Asia Pertussis Vaccine Production Capacity, 2015-2026
  7.1.2 Southeast Asia Pertussis Vaccine Production 2015-2026
  7.1.3 Southeast Asia Pertussis Vaccine Production Value 2015-2026
7.2 Key Local Pertussis Vaccine Manufacturers in Southeast Asia
  7.2.1 Southeast Asia Key Local Pertussis Vaccine Manufacturers Production Capacity
  7.2.2 Southeast Asia Key Local Pertussis Vaccine Manufacturers Production
  7.2.3 Southeast Asia Key Local Pertussis Vaccine Manufacturers Production Value
  7.2.4 The Proportion of Pertussis Vaccine Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
7.3 Pertussis Vaccine Export and Import in Southeast Asia
  7.3.1 Southeast Asia Pertussis Vaccine Export Market
  7.3.2 Southeast Asia Pertussis Vaccine Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Southeast Asia Pertussis Vaccine Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON PERTUSSIS VACCINE SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Pertussis Vaccine Distributors and Sales Agents in Southeast Asia

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Pertussis Vaccine in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Pertussis Vaccine Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Pertussis Vaccine Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Pertussis Vaccine Sales by Companies, (K Doses), 2015-2020
Table 6. Southeast Asia Pertussis Vaccine Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Pertussis Vaccine Price (2015-2020) (USD/Doses)
Table 8. Southeast Asia Manufacturers Pertussis Vaccine Product Type
Table 9. List of Southeast Asia Tier 1 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Pertussis Vaccine Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Pertussis Vaccine Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Pertussis Vaccine Sales in Southeast Asia (K Doses), 2015-2020
Table 14. By Type - Pertussis Vaccine Sales in Southeast Asia (K Doses), 2021-2026
Table 15. By Application - Pertussis Vaccine Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Pertussis Vaccine Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Pertussis Vaccine Sales in Southeast Asia, (K Doses), 2015-2020
Table 18. By Application - Pertussis Vaccine Sales in Southeast Asia, (K Doses), 2021-2026
Table 19. Sanofi Pasteur Corporate Summary
Table 20. Sanofi Pasteur Pertussis Vaccine Product Offerings
Table 21. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 22. GSK Corporate Summary
Table 23. GSK Pertussis Vaccine Product Offerings
Table 24. GSK Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 25. Mitsubishi Tanabe Pharma Corporate Summary
Table 26. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offerings
Table 27. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 28. Astellas Pharma Corporate Summary
Table 29. Astellas Pharma Pertussis Vaccine Product Offerings
Table 30. Astellas Pharma Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 31. Minhai Biotechnology Corporate Summary
Table 32. Minhai Biotechnology Pertussis Vaccine Product Offerings
Table 33. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 34. Wuhan Institute of Biological Products Corporate Summary
Table 35. Wuhan Institute of Biological Products Pertussis Vaccine Product Offerings
Table 36. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 37. Changchun Changsheng Life Sciences Corporate Summary
Table 38. Changchun Changsheng Life Sciences Pertussis Vaccine Product Offerings
Table 39. Changchun Changsheng Life Sciences Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 40. Pertussis Vaccine Production Capacity (K Doses) of Local Manufacturers in Southeast Asia, 2015-2020
Table 41. Pertussis Vaccine Production (K Doses) of Local Manufacturers in Southeast Asia, 2015-2020
Table 42. Southeast Asia Pertussis Vaccine Production Market Share of Local Manufacturers, 2015-2020
Table 43. Pertussis Vaccine Production Value (US$, Mn) of Local Manufacturers in Southeast Asia, 2015-2020
Table 44. Southeast Asia Pertussis Vaccine Production Value Market Share of Local Manufacturers, 2015-2020
Table 45. The Percentage of Pertussis Vaccine Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 46. The Percentage of Pertussis Vaccine Production Sold in Southeast Asia and Sold Other Than Southeast Asia by Manufacturers
Table 47. Dangeguojia Pertussis Vaccine Sales (Consumption), Production, Export and Import, 2015-2020
Table 48. Raw Materials and Suppliers
Table 49. Pertussis Vaccine Downstream Clients in Southeast Asia
Table 50. Pertussis Vaccine Distributors and Sales Agents in Southeast Asia

List Of Figures

LIST OF FIGURES

Figure 1. Pertussis Vaccine Segment by Type
Figure 2. Pertussis Vaccine Segment by Application
Figure 3. Dangeguojia Pertussis Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Pertussis Vaccine Market Size in Southeast Asia, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. Southeast Asia Pertussis Vaccine Revenue, 2015-2026 (US$, Mn)
Figure 7. Pertussis Vaccine Sales in Southeast Asia: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pertussis Vaccine Revenue in 2019
Figure 9. By Type - Southeast Asia Pertussis Vaccine Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Southeast Asia Pertussis Vaccine Market Share, 2015-2020
Figure 11. By Type - Southeast Asia Pertussis Vaccine Market Share, 2020-2026
Figure 12. By Type - Southeast Asia Pertussis Vaccine Price (USD/Doses), 2015-2026
Figure 13. By Application - Pertussis Vaccine Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 14. By Application - Southeast Asia Pertussis Vaccine Market Share, 2015-2020
Figure 15. By Application - Southeast Asia Pertussis Vaccine Market Share, 2020-2026
Figure 16. By Application -Southeast Asia Pertussis Vaccine Price (USD/Doses), 2015-2026
Figure 17. Southeast Asia Pertussis Vaccine Production Capacity (K Doses), 2015-2026
Figure 18. Southeast Asia Pertussis Vaccine Actual Output (K Doses), 2015-2026
Figure 19. Southeast Asia Pertussis Vaccine Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Southeast Asia Pertussis Vaccine Export Destination, 2019
Figure 21. The Source of Imports of Southeast Asia Pertussis Vaccine, 2019
Figure 22. PEST Analysis for Southeast Asia Pertussis Vaccine Market in 2020
Figure 23. Pertussis Vaccine Market Opportunities & Trends in Southeast Asia
Figure 24. Pertussis Vaccine Market Drivers in Southeast Asia
Figure 25. Pertussis Vaccine Market Restraints in Southeast Asia
Figure 26. Pertussis Vaccine Industry Value Chain